The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020
Open accessAbstract
Antigen-based tests for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), are inexpensive and can return results within 15 minutes (1). Antigen tests have received Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for use in asymptomatic and symptomatic persons within the first 5-12 days after symptom onset (2). These tests have been used at U.S. colleges and universities and other congregate settings (e.g., nursing homes and correctional and detention facilities), where serial testing of asymptomatic persons might facilitate early case identification (3-5). However, test performance data from symptomatic and asymptomatic persons are limited. This investigation evaluated performance of the Sofia SARS Antigen Fluorescent Immunoassay (FIA) (Quidel Corporation) compared with real-time reverse transcription-polymerase chain reaction (RT-PCR) for SARS-CoV-2 detection among asymptomatic and symptomatic persons at two universities in Wisconsin. During September 28-October 9, a total of 1,098 paired nasal swabs were tested using the Sofia SARS Antigen FIA and real-time RT-PCR. Virus culture was attempted on all antigen-positive or real-time RT-PCR-positive specimens. Among 871 (79%) paired swabs from asymptomatic participants, the antigen test sensitivity was 41.2%, specificity was 98.4%, and in this population the estimated positive predictive value (PPV) was 33.3%, and negative predictive value (NPV) was 98.8%. Antigen test performance was improved among 227 (21%) paired swabs from participants who reported one or more symptoms at specimen collection (sensitivity = 80.0%; specificity = 98.9%; PPV = 94.1%; NPV = 95.9%). Virus was isolated from 34 (46.6%) of 73 antigen-positive or real-time RT-PCR-positive nasal swab specimens, including two of 18 that were antigen-negative and real-time RT-PCR-positive (false-negatives). The advantages of antigen tests such as low cost and rapid turnaround might allow for rapid identification of infectious persons. However, these advantages need to be balanced against lower sensitivity and lower PPV, especially among asymptomatic persons. Confirmatory testing with an FDA-authorized nucleic acid amplification test (NAAT), such as RT-PCR, should be considered after negative antigen test results in symptomatic persons, and after positive antigen test results in asymptomatic persons (1).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lu, X., Wang, L., Sakthivel, S. K., Whitaker, B., Murray, J., Kamili, S., Lynch, B., Malapati, L., Burke, S. A., Harcourt, J., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2608.201246 · Cited by 676
Self-citationSevere Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Harcourt, J., Tamin, A., Lu, X., Kamili, S., Sakthivel, S. K., Murray, J., Queen, K., Tao, Y., Paden, C. R., Zhang, J., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2606.200516 · Cited by 542
Self-citationPaltiel, A. D., Zheng, A., & Walensky, R. P. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16818 · Cited by 445
Preventing and Responding to COVID-19 on College Campuses
Walke, H. T., Honein, M. A., & Redfield, R. (2020) · JAMA · doi:10.1001/jama.2020.20027 · Cited by 172
Gniazdowski, V., Paul Morris, C., Wohl, S., Mehoke, T., Ramakrishnan, S., Thielen, P., Powell, H., Smith, B., Armstrong, D. T., Herrera, M., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1616 · Cited by 169
Cited by
Brümmer, L. E., Katzenschlager, S., Gaeddert, M., Erdmann, C., Schmitz, S., Bota, M., Grilli, M., Larmann, J., Weigand, M. A., Pollock, N. R., et al. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003735 · Cited by 298
Jones, J. M., Stone, M., Sulaeman, H., Fink, R. V., Dave, H., Levy, M. E., Di Germanio, C., Green, V., Notari, E., Saa, P., et al. (2021) · JAMA · doi:10.1001/jama.2021.15161 · Cited by 201
Self-citation
Metadata
- Authors
- Pray, I. W., Ford, L., Cole, D., Lee, C., Bigouette, J. P., Abedi, G. R., Bushman, D., Delahoy, M. J., Currie, D., Cherney, B., Kirby, M., Fajardo, G., Caudill, M., Langolf, K., Kahrs, J., Kelly, P., Pitts, C., Lim, A., Aulik, N., Tamin, A., Harcourt, J. L., Queen, K., Zhang, J., Whitaker, B., Browne, H., Medrzycki, M., Shewmaker, P., Folster, J., Bankamp, B., Bowen, M. D., Thornburg, N. J., Goffard, K., Limbago, B., Bateman, A., Tate, J. E., Gieryn, D., Kirking, H. L., Westergaard, R., Killerby, M., CDC COVID-19 Surge Laboratory Group, CDC COVID-19 Surge Laboratory Group, Jiang, B., Vinjé, J., Hopkins, A. L., Katz, E., Barclay, L., Esona, M., Gautam, R., Mijatovic-Rustempasic, S., Moon, S.-S., Bessey, T., Chhabra, P., Smart, S. L., Anderson, R., Radford, K. W., Kim, G., Thompson, D., Miao, C., Chen, M.-H., Gade, L., Galloway, R., Sahibzada, K., Tran, N. M., Velusamy, S., Zheng, H., Nguyen, K., Hartloge, C., Jenkins, B., & Wong, P.
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2021-01-01
- Volume
- 69
- Issue
- 5152
- Pages
- 1642-1647
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W3113945020
- Cited by
- 255
- References
- 5
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020. https://app.cochat.ai/papers/10.15585/mmwr.mm695152a3
- The paper
- Pray, I. W., Ford, L., Cole, D., Lee, C., Bigouette, J. P., Abedi, G. R., Bushman, D., Delahoy, M. J., Currie, D., Cherney, B., Kirby, M., Fajardo, G., Caudill, M., Langolf, K., Kahrs, J., Kelly, P., Pitts, C., Lim, A., Aulik, N., . . . Wong, P. (2021). Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm695152a3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.